Answer | Antipsychotic | LA30297-8 |
Answer | Anticoagulant | LA30298-6 |
Answer | Antibiotic | LA30299-4 |
Answer | Opioid | LA28420-0 |
Answer | Antiplatelet | LA30300-0 |
Answer | Hypoglycemic (including insulin) | LA30301-8 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
answers-for | Drug classes that have an indication documented during assessment period [CMS Assessment] | 93154-3 |
LONG_COMMON_NAME | en-US | CMS_IRF-PAI v4.0 - HighRsk DrgUse IndNot (N0415-2) |
LOINC Version: 2.77